CRL vs TXO · rev $2.00B vs rev $401.0M
Charles River Laboratories (CRL) versus MorningStar Partners, L.P. (TXO) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
MorningStar Partners, L.P. (TXO) is a oil & gas e&p company listed on NYSE.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
Latest reported TXO revenue for 2025-12-31 was $401.0M. Net income was -$21.6M. Revenue was up 41.8% from 2024-12-31 to 2025-12-31. TXO currently screens at market cap $693.8M.
CRL currently screens at market cap $7.78B. TXO currently screens at market cap $693.8M.
Not investment advice. Open the CRL and TXO stock pages for the full models.
Not investment advice.